1. Home
  2. WST vs CBOE Comparison

WST vs CBOE Comparison

Compare WST & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CBOE
  • Stock Information
  • Founded
  • WST 1923
  • CBOE 1973
  • Country
  • WST United States
  • CBOE United States
  • Employees
  • WST N/A
  • CBOE N/A
  • Industry
  • WST Medical/Dental Instruments
  • CBOE Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • CBOE Finance
  • Exchange
  • WST Nasdaq
  • CBOE Nasdaq
  • Market Cap
  • WST 23.2B
  • CBOE 22.7B
  • IPO Year
  • WST N/A
  • CBOE 2010
  • Fundamental
  • Price
  • WST $322.65
  • CBOE $212.22
  • Analyst Decision
  • WST Buy
  • CBOE Buy
  • Analyst Count
  • WST 3
  • CBOE 12
  • Target Price
  • WST $460.33
  • CBOE $209.42
  • AVG Volume (30 Days)
  • WST 566.5K
  • CBOE 1.1M
  • Earning Date
  • WST 10-24-2024
  • CBOE 11-01-2024
  • Dividend Yield
  • WST 0.26%
  • CBOE 1.18%
  • EPS Growth
  • WST N/A
  • CBOE 10.63
  • EPS
  • WST 6.74
  • CBOE 7.34
  • Revenue
  • WST $2,876,400,000.00
  • CBOE $3,955,600,000.00
  • Revenue This Year
  • WST N/A
  • CBOE N/A
  • Revenue Next Year
  • WST $6.22
  • CBOE $4.85
  • P/E Ratio
  • WST $47.87
  • CBOE $29.19
  • Revenue Growth
  • WST N/A
  • CBOE 3.84
  • 52 Week Low
  • WST $265.00
  • CBOE $166.13
  • 52 Week High
  • WST $413.70
  • CBOE $221.66
  • Technical
  • Relative Strength Index (RSI)
  • WST 53.77
  • CBOE 54.91
  • Support Level
  • WST $315.17
  • CBOE $210.23
  • Resistance Level
  • WST $326.58
  • CBOE $221.66
  • Average True Range (ATR)
  • WST 9.63
  • CBOE 4.70
  • MACD
  • WST -0.42
  • CBOE 1.34
  • Stochastic Oscillator
  • WST 48.35
  • CBOE 63.83

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CBOE Cboe Global Markets Inc.

Cboe global Markets, Inc is a provider of market infrastructure and tradable products, delivers cutting-edge trading, clearing and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive global marketplace, and to providing leading products, technology and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.

Share on Social Networks: